MRVI

Conviction 91HealthcareScan · Mon, Aug 10, 2026

MRVI$6.06-2.81%

ResistanceSupportVol 14Insider sell

Vol MA14 2.14M

May 11May 28Jun 16Jul 6Jul 23Aug 10

MARAVAI LIFESCIENCES HOLDINGS, INC.PHARMACEUTICAL PREPARATIONSwww.maravai.com ↗

Price6.06

Change-2.81%

Gap-2.41%

Rel volume1.55×

Avg volume2.72M

Avg $ vol18.27M

SMA 206.71

SMA 505.97

SMA 2004.12

Price vs 50+1.35%

Price vs 200+47.10%

MA stackbullish

50/200 cross—

Supertrenddown · 6.94

RSI (14)41

MACD hist-0.14

MACD cross—

Stoch %K / %D32 / 27

ADX (14)33

+DI / −DI16 / 30

RSI divergenceBearish

MACD divergenceBearish

ATR %+5.88%

ADR %5.58%

52w high7.24

52w low2.06

From 52w high-16.37%

Above 52w low+193.93%

New 52w highNo

SqueezeOff

Bollinger width20.03%

%B0.01

Donchian pos31.77%

Donchian high7.44

Donchian low5.41

AVWAP (52w high)6.50

vs AVWAP high-6.78%

AVWAP (52w low)4.21

vs AVWAP low+43.68%

OBV trendFlat

Chaikin MF (20)0.16

Today vs 20d1.55×

Avg vol (14d)2.14M

Avg vol (20d)2.72M

Avg $ vol (20d)18.27M

Market cap874.1M

RS 3m (vs SPY)+52.42%

RS 6m (vs SPY)+87.50%

RS line new highNo

Trend template8/8

Technical rank68.4

1 week-5.69%

1 month-0.57%

3 months+24.85%

6 months+92.83%

1 year+199.01%

YTD+78.09%

P/E-6.68

P/B4.27

P/S4.71

P/FCF-12.36

EPS-0.9000

Div yield—

ROE-63.91%

ROA-21.66%

Debt/Eq0.72

Current4.05

EV/EBITDA—

Gross margin18.30%

Net margin-70.41%

Rev growth-28.34%

EPS growth9.72%

Price target6.25

Target upside3.22%

Analyst ratingHold

Institutional92.63%

Ent. value951.11M

Revenue51.44M

Net income-12.42M

Gross profit20.65M

Free cash flow-70.72M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out147.51M

Employees416

ListedFri, Nov 20, 2020

Free float117.94M

Float %80.6%

Short interest9.27M

Days to cover3.0d

Short volume71.5%

Squeeze score59 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.07 vs −$0.07

Last surprise0.0% beat

Setup gradeA+

Conviction91 / 100

Pattern quality—

Tech rank68.4 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance7.37

Support5.98

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in MRVI

All disclosures →

No recent disclosed trades by Congress in MRVI. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in MRVI · 4 buys · 5 sells

Insider	Side	Shares	Value	Traded	Filed
Brust Bernd Chief Executive Officer · Class A Common Stock · 2026-07-08	Tax	29.25K	$173K	2026-07-08	2026-07-10
ORESHACK KURT General Counsel · Class A Common Stock · 2026-06-10	Sell	25K	$128K	2026-06-10	2026-06-10
LUCIER GREGORY T Director · Class A Common Stock · 2026-06-09	Gift	46.29K	$0	2026-06-09	2026-06-10
ORESHACK KURT General Counsel · Class A Common Stock · 2026-06-09	Sell	25K	$127K	2026-06-09	2026-06-10
LUCIER GREGORY T Director · Class A Common Stock · 2026-06-09	Gift	46.29K	$0	2026-06-09	2026-06-10
Brust Bernd Chief Executive Officer · Class A Common Stock · 2026-06-08	Tax	351K	$1.8M	2026-06-08	2026-06-10
Brust Bernd Chief Executive Officer · Class A Common Stock · 2026-06-08	Other	—	—	2026-06-08	2026-06-10
MIHAS CONSTANTINE S Director · Class A Common Stock · 2026-05-26	Grant	46.29K	$0	2026-05-26	2026-05-28
LUCIER GREGORY T Director · Class A Common Stock · 2026-05-26	Grant	46.29K	$203K	2026-05-26	2026-05-28
CUNNINGHAM SEAN LAURENCE Director · Class A Common Stock · 2026-05-26	Grant	46.29K	$0	2026-05-26	2026-05-28

SEC filings

EDGAR filings in MRVI · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.